Immunovant, Inc. (IMVT) stock
IMVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$33.21−0.07 (-0.21%)
Close on Nov 17, 2026Market cap $6.86BP/E –Yield –
Immunovant operating margin
Operating margin is operating income as a percentage of revenue.
No operating margin figures for Immunovant
Immunovant has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?